Qelbree ER 200 MG capsule 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FFL8C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,540
Award facts
- Contract value 100% obligated
- $33,540.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $33.5K to AmerisourceBergen Drug Corp for QELBREE ER 200 MG capsules (60-count units) on January 29, 2026, with a completion date of January 30, 2026. This competitively awarded, firm fixed-price contract involved no set-aside designation and specifies performance at the awardee's facility in Conshohocken, Pennsylvania. QELBREE (viloxazine) is a non-stimulant medication used to treat attention-deficit/hyperactivity disorder (ADHD), indicating this delivery order supports the Defense Health Agency's pharmaceutical supply needs for military healthcare programs.
This delivery order operates under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.9M through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains a comprehensive contract vehicle enabling it to supply a diverse range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems globally. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary long-term IDC with DLA through December 2031, positioning the organization as a key strategic partner in federal pharmaceutical procurement.
Quick answers
Who was awarded contract SPE2DR26FFL8C?
SPE2DR26FFL8C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FFL8C worth?
The government has obligated $33,540 on SPE2DR26FFL8C.
Is contract SPE2DR26FFL8C an order under another contract?
Yes. SPE2DR26FFL8C is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL8C competed?
The extent of competition for SPE2DR26FFL8C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award